Rchr
J-GLOBAL ID:200901031052392110   Update date: Feb. 05, 2025

Tsuji Atsushi

ツジ アツシ | Tsuji Atsushi
Affiliation and department:
Homepage URL  (2): https://www.qst.go.jp/site/qms/1897.htmlhttps://www.qst.go.jp/site/nirs-english/1364.html
Research field  (5): Tumor diagnostics and therapeutics ,  Radiology ,  Cell biology ,  Molecular biology ,  Laboratory animal science
Research keywords  (8): Nuclear Medicine ,  分子イメージング ,  腫瘍イメージング ,  機能スクリーニング ,  放射線感受性 ,  分子生物 ,  遺伝育種 ,  molecular imaging
Research theme for competitive and other funds  (16):
  • 2022 - 2025 Development of the theranostic strategy SMART-PaC for pancreatic cancer
  • 2018 - 2023 難治性固形癌予後改善に資する間質バリアを克服するための新規放射免疫療法戦略の開発
  • 2016 - 2019 Proof of the next generation PET concept "Whole Gamma Imaging"
  • 2016 - 2019 Design and synthesis of novel amino acid PET tracer
  • 2015 - 2018 Investigation of the molecular mechanism of transiently elevated tumor uptake of PET tracers at early time points after X-ray radiation
Show all
Papers (109):
  • Zhao-Hui Jin, Mélissa Degardin, Takako Furukawa, Tomoya Uehara, Atsushi B. Tsuji, Hiroyuki Suzuki, Hidekatsu Wakizaka, Aya Sugyo, Winn Aung, Hisashi Suzuki, et al. Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD Peptide. ACS Omega. 2025
  • Sodai Takyu, Hideaki Tashima, Miwako Takahashi, Eiji Yoshida, Hidekatsu Wakizaka, Fujino Obata, Go Akamatsu, Kotaro Nagatsu, Aya Sugyo, Hitomi Sudo, et al. A whole gamma imaging prototype for higher quantitative imaging of89Zr-labeled antibodies in a tumor mouse model. Physics in medicine and biology. 2025. 70. 2
  • Miwako Takahashi, Taiga Yamaya, Kimiteru Ito, Shunsuke Kurosawa, Takahiro Higuchi, Atsushi Tsuji. Proposal of Change from SPECT to PET Aiming at Highly Reliable Diagnosis. RADIOISOTOPES. 2024
  • Nobuyuki Oguri, Toshihiro Gi, Eriko Nakamura, Eiji Furukoji, Hiroki Goto, Kazunari Maekawa, Atsushi B. Tsuji, Ryuichi Nishii, Murasaki Aman, Sayaka Moriguchi-Goto, et al. Expression of fibroblast activation protein-α in human deep venous thrombus. 2024
  • Kentaro Fujiwara, Atsushi B Tsuji, Hitomi Sudo, Aya Sugyo, Takao Hamakubo, Tatsuya Higashi. The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice. Nuclear medicine communications. 2024. 45. 1. 68-76
more...
MISC (108):
  • 山崎香奈, 西井龍一, 西井龍一, 辻厚至, 谷幸太郎, 橋本裕輝, 河村和紀, 張明栄, 田村謙太郎, 東達也. 新規アミノ酸PETプローブ11C-MeProを用いたfirst-in-humanイメージング試験. 核医学(Web). 2023. 60. Supplement
  • 尾幡穂乃香, 尾幡穂乃香, 辻厚至, 永津弘太郎, 小川美香子, ZHANG Ming Rong. Development of 191Pt-labeled compounds inducing DNA damage efficiently. 日本薬学会年会要旨集(Web). 2023. 143rd
  • 前川和也, 辻厚至, 山下篤, 須堯綾, 西平賢作, 柴田剛徳, 張明栄, 西井龍一, 浅田祐士郎. Translocator proteinは冠動脈不安定プラーク内マクロファージに局在し,18F-FEDAC-PETは家兎動脈硬化病変を描出する. 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web). 2022. 54th
  • 田村謙太郎, 西井龍一, 辻厚至, 谷幸太郎, 橋本裕輝, 河村和紀, 張明栄, 山崎香奈, 今林悦子, 東達也. TSPOの特異的PETリガンド[18F]FEDACの臨床第I相試験. 核医学(Web). 2022. 59. Supplement
  • 山崎香奈, 西井龍一, 辻厚至, 谷幸太郎, 橋本裕輝, 河村和紀, 張明栄, 田村謙太郎, 今林悦子, 東達也. 膵癌診断を目的とした新規アミノ酸PETプローブの臨床第I相試験. 核医学(Web). 2022. 59. Supplement
more...
Professional career (1):
  • 博士 (浜松医科大学)
Association Membership(s) (1):
JAPANESE SOCIETY OF NUCLEAR MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page